Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-throughput T cell receptor engineering by functional screening identifies candidates with enhanced potency and specificity.
Vazquez-Lombardi R, Jung JS, Schlatter FS, Mei A, Mantuano NR, Bieberich F, Hong KL, Kucharczyk J, Kapetanovic E, Aznauryan E, Weber CR, Zippelius A, Läubli H, Reddy ST. Vazquez-Lombardi R, et al. Among authors: kucharczyk j. Immunity. 2022 Oct 11;55(10):1953-1966.e10. doi: 10.1016/j.immuni.2022.09.004. Epub 2022 Sep 28. Immunity. 2022. PMID: 36174557 Free article.
Engineered allogeneic T cells decoupling T-cell-receptor and CD3 signalling enhance the antitumour activity of bispecific antibodies.
Kapetanovic E, Weber CR, Bruand M, Pöschl D, Kucharczyk J, Hirth E, Dietsche C, Khan R, Wagner B, Belli O, Vazquez-Lombardi R, Castellanos-Rueda R, Di Roberto RB, Kalinka K, Raess L, Ly K, Rai S, Dittrich PS, Platt RJ, Oricchio E, Reddy ST. Kapetanovic E, et al. Among authors: kucharczyk j. Nat Biomed Eng. 2024 Dec;8(12):1665-1681. doi: 10.1038/s41551-024-01255-x. Epub 2024 Sep 25. Nat Biomed Eng. 2024. PMID: 39322719 Free PMC article.
The Impact of Liver Failure on the Immune System.
Dąbrowska A, Wilczyński B, Mastalerz J, Kucharczyk J, Kulbacka J, Szewczyk A, Rembiałkowska N. Dąbrowska A, et al. Among authors: kucharczyk j. Int J Mol Sci. 2024 Sep 1;25(17):9522. doi: 10.3390/ijms25179522. Int J Mol Sci. 2024. PMID: 39273468 Free PMC article. Review.
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 Pandemic.
Marks DK, Budhathoki N, Kucharczyk J, Fa'ak F, D'Abreo N, Kwa M, Plasilova M, Dhage S, Soe PP, Becker D, Hindenburg A, Lee J, Winner M, Okpara C, Daly A, Shah D, Ramdhanny A, Meyers M, Oratz R, Speyer J, Novik Y, Schnabel F, Jones SA, Adams S. Marks DK, et al. Among authors: kucharczyk j. Oncologist. 2022 Mar 4;27(2):89-96. doi: 10.1093/oncolo/oyab042. Oncologist. 2022. PMID: 35641208 Free PMC article.
Quantitative Multiplex Immunofluorescence Evaluation of the Tumor Microenvironment in Pretreatment Tumors of Patients with Metastatic Breast Cancer and Serous Ovarian Carcinoma Treated with Liposomal Eribulin.
Marks DK, Kucharczyk J, Kim P, Chyong DI, Gartrell RD, Lu Y, Hibshoosh H, Guo H, Evans TRJ, Lopez J, Kristeleit R, Connolly E, Saenger Y, Kalinsky K. Marks DK, et al. Among authors: kucharczyk j. Cancer Invest. 2021 Jul-Aug;39(6-7):466-472. doi: 10.1080/07357907.2021.1938109. Epub 2021 Jun 21. Cancer Invest. 2021. PMID: 34075851
Targeting Toll-Like Receptors for Cancer Therapy.
Braunstein MJ, Kucharczyk J, Adams S. Braunstein MJ, et al. Among authors: kucharczyk j. Target Oncol. 2018 Oct;13(5):583-598. doi: 10.1007/s11523-018-0589-7. Target Oncol. 2018. PMID: 30229471
Emerging Immunotargets in Metastatic Renal Cell Carcinoma.
Kucharczyk J, Matrana MR, Santoni M, Massari F, Scarpelli M, Cheng L, Lopez-Beltran A, Cascinu S, Montironi R, Holger M. Kucharczyk J, et al. Curr Drug Targets. 2016;17(7):771-6. doi: 10.2174/1389450117666151209115753. Curr Drug Targets. 2016. PMID: 26648075 Review.
122 results